The characteristic common to all graphene structures observed in blood is that they consume red cells, perhaps for their iron content, and in production of hybrid structures of various types and purpose.
These can be the beginnings of red cell clots or amyloid clots. We have proven that EDTA chelation therapy breaks up these clots and helps remove them from the body.
